Cancer Treatment Centers of America

The CTCA blog

Study: Immunotherapy better than chemotherapy in some hard-to-treat lung cancer cases


A new study concluded that immunotherapy is more effective than chemotherapy in extending the lives of some patients with advanced lung cancer. In the study, published Dec. 19 in The Lancet medical journal, researchers studied about 1,000 patients with non-small lung cancers who continued to battle tumors that had progressed despite having at least two rounds of chemotherapy.

Keeping a cancer diagnosis private: David Bowie isn't alone


When the news broke late Sunday night that musical legend David Bowie had died at the age of 69 after an 18-month battle with cancer, fans around the world expressed not just grief but shock. Despite more than five decades on the world stage, under the glare of a public spotlight, the rock-and-roll icon managed to keep his cancer journey a secret from fans and friends alike, sharing it only with a handful of people in his inner circle.

To test or not to test: The PSA and your prostate cancer risk


For men seeking clarity on whether to undergo routine prostate cancer screening, two recent studies in the Journal of the American Medical Association (JAMA) may raise new questions. Since 2012, there’s been a drop in the routine use of the blood test known as the PSA, short for prostate-specific antigen, according to the studies published on Nov. 17. Meanwhile, fewer prostate cancers are being diagnosed.

Natural supplements for cancer patients: 7 to avoid


Natural supplements—the very words sound healthy. Many times, they are. Adding vitamins, minerals and other natural remedies to your daily regimen can boost some people’s immune system, energy level and overall health. But if you’ve been diagnosed with cancer, and especially if you are undergoing treatment, certain supplements may actually harm you.

Stage 0 breast cancer dilemma: To treat or not to treat?


“You have breast cancer.” About 50,000 women will hear those words in 2015, according to the American Cancer Society (ACS). But unlike the approximately 234,000 with invasive malignancies, these women will be diagnosed with stage 0 breast cancer. Also known as ductal carcinoma in situ, or DCIS, it is considered non-invasive because the cancer cells have not spread beyond the milk duct. Some patients are drawing attention for what they're doing about the disease—nothing at all in terms of treatment.